Neurofilament light (NFL), soluble TREM2 (sTREM2) and neurogranin are promising new biomarkers for Alzheimer’s disease (AD), but it is not clear whether they are specific for parenchymal amyloid. The gene discussed is NRGN; the disease is amyloidosis.